Pathway-based Bayesian factor models for gene expression data
Lorenzo Mauri, Federica Stolf, Amy H. Herring, Cameron Miller, David B. Dunson · 2026
Read Pathway-based Bayesian factor models for gene expression data by Lorenzo Mauri, Federica Stolf, Amy H. Herring, Cameron Miller, David B. Dunson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2601-13419.txt.
Introduction
Lorenzo Mauri and co-authors read gene data through the pathways genes serve, not just one gene at a time. Gene marks make sense in groups. A pathway is a set of genes that run one cell job. Old tools cut data dims with no tie to such groups, so their parts can lack a clear life sense.
Pathway led tools do exist, but they oft bind with stiff terms or need huge hand work. The team builds Bayes factor models that take pathway notes in a flex way. Latent parts then map to real cell jobs. For bio teams, parts with a life sense beat parts that just fit sums.
Catalog record
| CREATOR | Lorenzo Mauri, Federica Stolf, Amy H. Herring, Cameron Miller, David B. Dunson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2601-13419
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Pathway-based Bayesian factor models for gene expression data Lorenzo Mauri, Federica Stolf, Amy H. Herring, Cameron Miller, David B. Dunson Abstract Interpreting gene expression data requires methods that can uncover coordinated patterns corresponding to biological pathways. Traditional approaches such as principal component analysis and factor models reduce dimensionality, but latent components may have unclear biological meaning. Current approaches to incorporate pathway annotations impose restrictive assumptions, require extensive hyperparameter tuning, and do not provide principled uncertainty quantification, hindering the robustness and reproducibility of results. Here, we develop Bayesian Analysis with gene-Sets Informed Latent space (BASIL), a scalable Bayesian factor modeling framework that incorporates gene pathway annotations into latent variable analysis for RNA-sequencing data. BASIL places structured priors on factor loadings, shrinking them toward combinations of annotated gene sets, enhancing biological interpretability and stability, while simultaneously learning new unstructured components. BASIL provides accurate covariance estimates and uncertainty quantification, without resorting to computationally expensive Markov chain Monte Carlo sampling. An automatic empirical Bayes procedure eliminates the need for manual hyperparameter tuning, promoting reproducibility and usability in practice. In simulations and large-scale human transcriptomic datasets, BASIL consistently outperforms state-of-the-art approaches, accurately reconstructing gene–gene covariance, selecting the correct latent dimension, and identifying biologically coherent modules. Main Text High-throughput transcriptomic technologies generate measurements for tens of thousands of genes, creating data with immense promise, but also fundamental challenges in statistical analysis, especially when the number of samples is not very large. One central task in the analysis of gene expression from high-throughput RNA-sequencing data is to extract relevant biological insights. Patterns of correlated expression among genes are frequently observed in such datasets and can reflect coordinated transcriptional regulation, in which genes involved in the same pathway or cellular function are regulated in concert to maintain synchronized activity ( 27 ) . Accurate discovery of biologically relevant signals in massive dimensional noisy data is crucial for understanding the molecular mechanisms driving differences across conditions, cell types, or perturbations. Matrix factorization techniques, such as principal component analysis (PCA) or factor analysis, are widely used to infer components of variation in multivariate gene expression data. These methods rely on low-dimensional latent variable representations that can offer biologically meaningful interpretations. Factor models can be used to infer gene co-expression networks by identifying pairs of genes whose expression profiles are significantly associated across samples ( 32 ) . Constructing such networks is a key objective in many biological studies, as it enables researchers to uncover novel gene interactions and functional relationships. Structured matrix factorizations have been proposed to incorporate biological knowledge. Examples include leveraging gene–gene interaction networks to guide factors towards known pathways ( 10 ) and using gene perturbation data to associate factors with perturbation effects in single-cell CRISPR screens ( 44 ) . Other contributions target scRNA-seq data ( 2 ; 15 ) . In this work, we focus on bulk RNA-sequencing data and use gene sets as prior information. The state of the art in this setting is PLIER (pathway-level information extractor) ( 21 ) , a matrix factorization approach that maps gene expression data into a low-dimensional space. Integrating pathway-informed annotations improves interpretability by yielding latent components aligned with known pathways. The PLIER framework has been extensively refined ( 30 ; 34 ; 43 ) , but key problems remain. First, it restricts factor loadings to be positive, which rules out commonly observed and biologically meaningful negative correlations ( 42 ; 36 ) . Hence, PLIER estimates need ad hoc post-processing, which results in sub-optimal accuracy, as we will show in our numerical experiments. PLIER is highly sensitive to hyperparameter choices, requiring computationally expensive tuning and potentially leading to poor recovery of the empirical gene correlation structure (fig. 1 b). Furthermore, PLIER and related methods (e.g. 2 ) do not provide uncertainty quantification (UQ) in the inferred gene-gene covariance. To overcome these limitations, we develop Bayesian Analysis with gene-Sets Informed Latent space (BASIL). BASIL is based on a probabilistic matrix factorization framework and specifically adopts a Bayesian learning paradigm, which has several advantages in this setting. Bayesian methods offer a natural way to incorporate known gene sets through structured prior distributions and provide straightforward uncertainty quantification. The proposed approach projects high-dimensional gene expression data onto a low-dimensional set of latent factors, each representing an interpretable combination of gene sets. By integrating knowledge of gene sets, these latent variables capture structured variation in expression and provide meaningful insights into molecular processes. BASIL relies on a scalable and computationally efficient algorithm that enables fast inference even when analyzing 10,000s of genes. We assess performance through extensive simulation studies and analysis of gene expression datasets. The results demonstrate that BASIL not only identifies biologically significant gene modules but also achieves superior predictive accuracy compared to state of the art approaches. Figure 1: BASIL overview . a , BASIL is a two-layer matrix factorization approach: in the top layer the gene expression matrix ( Y ) is factorized as the product of a small number of latent variables ( M ) and their corresponding gene weights ( \Lambda ); in the hierarchical layer BASIL exploits prior gene ontology – the binary gene set membership matrix C – in the definition of \Lambda . b, Empirical gene-gene correlation matrix computed from a subset of 100 genes for a gene expression dataset (global fever data) and correlation matrices estimated with BASIL and PLIER, reconstructed through latent variable factorization. The scatter plots show observed versus predicted correlation values. Results Overview of gene sets informed factor models BASIL is a Bayesian factor model that incorporates biological pathway information through a structured prior distribution. The input of BASIL consists of two matrices: a normalized gene expression matrix across samples (Y) and a binary gene membership matrix (C) based on prior knowledge. The matrix Y may consist of gene expression data from RNA sequencing or microarray experiments in which rows represent samples and columns represent genes. Each column of C corresponds to a molecular pathway, gene ontology set or any other predefined gene collection of interest. The proposed approach factorizes the gene expression matrix into the product of the factor matrix (M) and the gene weight matrix (\Lambda) plus a residual noise matrix (E) . To incorporate gene pathway information, BASIL defines a hierarchical structure in the gene weights matrix, introducing a second layer in the model (fig. 1 a). Specifically, we assume that \Lambda is the sum of two components: the product of the gene set matrix ( C ) and a linkage matrix \Gamma , and a newly discovered gene set matrix ( \Psi ). The matrix \Gamma is a graphical matrix that encodes the association between latent variables and gene sets or pathways, promoting a biologically meaningful interpretation of the latent space. This structure allows for the incorporation of known gene ontology information while addressing the fact that many genes are not in any existing gene set. By modeling these two components separately, BASIL enhances both interpretability and flexibility. This represents a key advantage over PLIER ( 21 ) , which does not explicitly distinguish between structured and unstructured sources of variability. The unknown quantities that we want to infer from the data are the factor matrix M , the gene weight matrix \Lambda